![Art Gilliland](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Art Gilliland
Algemeen Directeur bij Delinea, Inc. (United States)
Profiel
Art Gilliland is currently the Chief Executive Officer at Delinea Corp.
and the Chief Executive Officer & Director at Delinea, Inc.
Actieve functies van Art Gilliland
Bedrijven | Functie | Begin |
---|---|---|
Delinea, Inc. (United States)
![]() Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Algemeen Directeur | 01-03-2021 |
Delinea Corp.
![]() Delinea Corp. Information Technology ServicesTechnology Services Delinea Corp. provides information technology, outsourcing and consulting services for the energy and utility industries. Its services include outsourcing and service hosting, business development, consulting, training and support. The company also provides infrastructure management, asset management and project management. The firm was founded by Kevin Wright in April, 2000 and is located in Delinea, TX. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Delinea, Inc. (United States)
![]() Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Health Technology |
Delinea Corp.
![]() Delinea Corp. Information Technology ServicesTechnology Services Delinea Corp. provides information technology, outsourcing and consulting services for the energy and utility industries. Its services include outsourcing and service hosting, business development, consulting, training and support. The company also provides infrastructure management, asset management and project management. The firm was founded by Kevin Wright in April, 2000 and is located in Delinea, TX. | Technology Services |